纤毛指数在疑难Spitz样黑色素细胞肿瘤中的诊断价值
该研究评估了纤毛指数(CI)在68例Spitz样肿瘤(包括Spitz痣、非典型Spitz肿瘤和Spitz样黑色素瘤)中的诊断价值。结果显示Spitz样黑色素瘤组的CI显著低于Spitz痣或非典型Spitz肿瘤组。基于机器学习算法,低CI被一致列为恶性肿瘤诊断的顶级预测特征,且仅使用CI、不对称性、深染和细胞异型性四个特征的预测模型在56例独立验证队列中优于标准组织学评估。
要点
- Spitz样黑色素瘤的纤毛指数显著低于Spitz痣和非典型Spitz肿瘤。
- 低纤毛指数是诊断恶性肿瘤的顶级预测特征之一。
- 联合纤毛指数与不对称性、深染、细胞异型性的模型优于标准组织学评估。
核心结论
- 纤毛指数是鉴别Spitz样黑色素瘤与Spitz痣/非典型Spitz肿瘤的有用辅助诊断工具。
研究设计与样本
- 评估68例Spitz样肿瘤(从Spitz痣、非典型Spitz肿瘤到Spitz样黑色素瘤)的纤毛指数,并使用机器学习算法结合其他组织病理学和分子特征进行分析,在56例独立验证队列中验证模型。
主要发现
- Spitz样黑色素瘤组的纤毛指数显著低于Spitz痣组和非典型Spitz肿瘤组。
- 低纤毛指数被一致列为恶性肿瘤诊断的顶级预测特征。
- 仅基于纤毛指数、不对称性、深染和细胞异型性四个特征的预测模型在独立验证队列中优于标准组织学评估。
临床怎么用
- 纤毛指数可作为辅助诊断测试,用于评估诊断困难的黑色素细胞病变,尤其是Spitz样肿瘤。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The loss of primary cilia on melanocytes is a useful biomarker for the distinction of melanoma from conventional melanocytic nevi. It is unknown whether ciliation status is beneficial for diagnosing spitzoid tumors-a subclass of melanomas that present inherently ambiguous histology and are challenging to classify. We evaluated the Ciliation Index (CI) in 68 cases of spitzoid tumors ranging from Spitz nevi and atypical Spitz tumors to spitzoid melanoma. We found a significant decrease in CI within the spitzoid melanoma group when compared with either the Spitz nevi or atypical Spitz tumors groups. In addition, we used a machine-learning-based algorithm to determine the value of CI when considered in combination with other histopathologic and molecular features commonly used for diagnosis. We found that a low CI was consistently ranked as a top predictive feature in the diagnosis of malignancy. Predictive models trained on only the top four predictive features (CI, asymmetry, hyperchromatism, and cytologic atypia) outperformed standard histologic assessment in an independent validation cohort of 56 additional cases. The results provide an alternative approach to evaluate diagnostically challenging melanocytic lesions, and further support the use of CI as an ancillary diagnostic test.
引用
- Lang UE, Torres R, Cheung C, et al. Ciliation Index Is a Useful Diagnostic Tool in Challenging Spitzoid Melanocytic Neoplasms. J Invest Dermatol. 2020. PMID: 31978411. doi:10.1016/j.jid.2019.11.028
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。